Please assess the completion status of the following clinical trial:

Trial Title: The Acute Effect of Hypericum Perforatum on Short-Term Memory in Healthy Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* healthy adults 18 to 40 years old.~Exclusion Criteria:~* 1. Demographics: Under 18 years of age or older than 40; pregnant or nursing women; non-fluent Hebrew speakers.~  2. Body weight: less than 50 kg and more than 90 kg (to ensure effective drug dosage).~  3. Mental health: Diagnosed with any DSM-V disorder (including ADHD, learning disabilities). These DSM-V disorders may be included in the research: sexual dysfunctions, sleeping disorders and mild-moderate anxiety disorders.~  4. Any motor disability hampering a participant's ability to perform the experimental task.~  5. Consumption of any psychoactive substance within the last 72 hours. 6. Ongoing medical problems or use of any substances (e.g., other prescribed medications) which may interact negatively with any of the three drugs used in the experiment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Hypericum perforatum (Remotiv, 250 mg) (Type: EXPERIMENTAL): None
- Hypericum perforatum (Remotiv, 500 mg) (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).